Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2007; 13(3): 432-437
Published online Jan 21, 2007. doi: 10.3748/wjg.v13.i3.432
Table 1 Demographic, clinical, and laboratory data of the total study group on arrival at the Emergency Department (n = 150)
ValueVariable
Age (yr)163.8 ± 1.3 (65.0) (range: 16-98)
Sex (Male/Female)2M: 60 (40%)/F: 90 (60%)
Time between onset of symptoms and arrival (h)133.5 ± 2.3 (24.0) (range: 2-120)
Systolic arterial blood pressure (mmHg)1121.2 ± 1.7 (120.0) (range: 80-170)
Diastolic arterial blood pressure (mmHg)162.1 ± 0.9 (65.0) (range: 40-90)
Heart rate (/min)180.4 ± 0.8 (79.5) (range: 60-130)
Breathing rate (/min)115.4 ± 0.1 (15.0) (range:11-22)
Body temperature (°C)136.4 ± 0.03 (36.4) (range: 35.5-37.4)
Fever (temperature > 38.0°C)20 (0%)
Absence of passage of flatus2135 (90%)
Absence of passage of feces2121 (80.6%)
Vomiting2118 (78.6%)
Nausea289 (59.3%)
Abdominal discomfort299 (66%)
Abdominal distension298 (65.3%)
Colicky abdominal pain2111 (74%)
Continuous abdominal pain222 (14.6%)
Abdominal muscle guarding256 (37.3%)
Rebound tenderness27 (4.6%)
Small bowel obstruction2114 (76%)
Large bowel obstruction236 (24%)
White blood cell (WBC) count (109/L)19.93 ± 0.29 (8.90) [range: 3.58-24.4]
Leukocytosis2 (WBC count > 10.8 × 109/L)255 (36.6%)
Table 2 Etiology of acute mechanical bowel obstruction n (%)
CauseSmall bowelobstructiongroup (n = 114)Large bowelobstructiongroup (n = 36)Total studygroup(n = 150)
Adhesions84 (73.8%)13 (36.3%)97 (64.8%)
Hernia21 (18.5%)1 (2.7%)22 (14.8%)
Large bowel cancer3 (2.6%)17 (47.4%)20 (13.4%)
Small bowel tumor3 (2.6%)0 (0%)3 (2.0%)
Retroperitoneal tumor0 (0%)2 (5.5%)2 (1.3%)
Crohn’s disease2 (1.7%)0 (0%)2 (1.3%)
Small bowel volvulus1 (0.8%)0 (0%)1 (0.6%)
Ovarian cystadenocarcinoma0 (0%)1 (2.7%)1 (0.6%)
Acute diverticulitis0 (0%)1 (2.7%)1 (0.6%)
Sigmoid volvulus0 (0%)1 (2.7%)1 (0.6%)
Table 3 Management and outcome of the patients
ValueSmall bowelobstructiongroup (n = 114)Large bowelobstructiongroup (n = 36)Total studygroup(n = 150)
Operative treatment135 (30.7%)27 (75%)62 (41.3%)
Nonoperative treatment179 (69.3%)9 (25%)88 (58.7%)
Time between arrival and operation (h)230.2 ± 4.1 (10.0) [range: 2-96]71.2 ± 3.2 (78.0) [range: 4-164]48.1 ± 4.2 (26.0) [range: 2-164]
Operation on the 1st day122 (19.3%)7 (19.4%)29 (19.3%)
Operation on the 2nd day14 (3.5%)2 (5.5%)6 (4%)
Operation on the 3rd day15 (4.3%)3 (8.3%)8 (5.3%)
Complication14 (3.5%)2 (5.5%)6 (4%)
Intensive Care Unit (ICU) admission16 (5.2%)3 (8.3%)9 (6%)
ICU length of stay (d)26.3 ± 0.5 (2.0) [range: 1-25]4.0 ± 0.7 (5.0) [range: 2-5]5.5 ± 2.4 (3.0) [range: 1-25]
Hospital length of stay (d)26.0 ± 0.6 (5.0) [range: 2-32]9.8 ± 1.1 (11.0) [range: 3-20]6.9 ± 0.3 (6.0) [range: 2-32]
Mortality11 (0.8%)1 (2.7%)2 (1.3%)
Table 4 Incidence of bowel ischemia, necrosis, and perforation n (%)
ValueSmall bowelobstructiongroup (n = 114)Large bowelobstructiongroup (n = 36)Total studygroup(n = 150)
Ischemia15 (13.2%)6 (16.6%)21 (14%)
Necrosis8 (7%)6 (16.6%)14 (9.3%)
Perforation4 (3.5%)4 (11.1%)8 (5.3%)
Table 5 Etiology of small bowel ischemia, necrosis, and perforation (small bowel obstruction group, n = 114) n (%)
CauseIschemia(n = 15)Necrosis(n = 8)Perforation(n = 4)
Hernia11 (73.3%)5 (62.5%)3 (75%)
Adhesions2 (13.3%)2 (25%)1 (25%)
Small bowel volvulus1 (6.7%)1 (12.5%)0 (0%)
Large bowel cancer1 (6.7%)0 (0%)0 (0%)
Small bowel tumor0 (0%)0 (0%)0 (0%)
Table 6 Etiology of large bowel ischemia, necrosis, and perforation (large bowel obstruction group, n = 36) n (%)
CauseIschemia(n = 6)Necrosis(n = 6)Perforation(n = 4)
Large bowel cancer3 (50%)3 (50%)2 (50%)
Adhesions1 (16.6%)1 (16.6%)1 (25%)
Hernia1 (16.6%)1 (16.6%)1 (25%)
Sigmoid volvulus1 (16.6%)1 (16.6%)0 (0%)
Retroperitoneal tumor0 (0%)0 (0%)0 (0%)
Ovarian cystadenocarcinoma0 (0%)0 (0%)0 (0%)
Table 7 Etiology of bowel ischemia, necrosis, and perforation (total study group, n = 150) n (%)
CauseIschemia(n = 21)Necrosis(n = 14)Perforation(n = 8)
Hernia12 (57.2%)6 (42.8%)4 (50%)
Large bowel cancer4 (19.1%)3 (21.4%)2 (25%)
Adhesions3 (14.3%)3 (21.4%)2 (25%)
Small bowel volvulus1 (4.7%)1 (7.2%)0 (0%)
Sigmoid volvulus1 (4.7%)1 (7.2%)0 (0%)
Small bowel tumor0 (0%)0 (0%)0 (0%)
Retroperitoneal tumor0 (0%)0 (0%)0 (0%)
Ovarian cystadenocarcinoma0 (0%)0 (0%)0 (0%)